Inclusion Criteria:

- MSKCC Histologically confirmed ovarian, fallopian tube or primary peritoneal
carcinoma.

- Patient has received at least one prior platinum-containing (cisplatin or
carboplatin) regimen

- Age ≥ 21 years old

- Karnofsky Performance Status (KPS) > or = to 70%

- Adequate hematologic, hepatic and renal function as defined below:

- Hemoglobin ≥ 7.0 g/dl

- Absolute neutrophil count ≥ 1,000/mm3

- Platelet count ≥ 100,000/mm3

- Serum creatinine ≤ 1.5 x the upper limit of normal or calculated creatinine clearance
≥ 60 mL/min

Exclusion Criteria:

- Prior carboplatin or cisplatin hypersensitivity reaction

- Uncontrolled intercurrent illness including infection, congestive heart failure,
myocardial infarction, transient ischemic attack or stroke within 6 months. Any such
conditions that have occurred in the last 6 months but are no longer active at the
time of registration are not considered exclusionary.

- Patients receiving other investigational agents

- Patients with HIV disease will be permitted, only if they are on effective
antiretroviral therapy, have a CD4 count greater than 400, and have had no
opportunistic infections within the past 6 months

- Pregnant or lactating women

- Life expectancy of less than 12 weeks